Rimonabant
Drug
Rimonabant is an anorectic antiobesity drug approved in Europe in 2006 but was withdrawn worldwide in 2008 due to serious psychiatric side effects; it was never approved in the United States. Rimonabant is an inverse agonist for the cannabinoid... Wikipedia
Molar mass: 463.79 g/mol
AHFS/Drugs.com: Consumer Drug Information
Bioavailability: Undetermined
Excretion: Fecal (86%) and renal (3%)
Metabolism: Hepatic, CYP3A4 involved
Pregnancy category: Not assigned, use not recommended